Indications and Purposes
| 1 Indications And Usage Zinecard Is Indicated For Reducing The Incidence And Severity Of Cardiomyopathy Associated With Doxorubicin Administration In Women With Metastatic Breast Cancer Who Have Received A Cumulative Doxorubicin Dose Of 300 Mg/m 2 And Who Will Continue To Receive Doxorubicin Therapy To Maintain Tumor Control. Do Not Use With The Initiation Of Doxorubicin Therapy [See Warnings And Precautions (5.2) ] . Zinecard Is A Cytoprotective Agent Indicated For Reducing The Incidence And Severity Of Cardiomyopathy Associated With Doxorubicin Administration In Women With Metastatic Breast Cancer Who Have Received A Cumulative Doxorubicin Dose Of 300 Mg/m 2 And Who Will Continue To Receive Doxorubicin Therapy To Maintain Tumor Control. Do Not Use Zinecard With Doxorubicin Initiation. ( 1 ) |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Dexrazoxane Hydrochloride |
|
ZINC87515509 |